Comparing helmet ventilation, CPAP, and high-flow oxygen for respiratory failure
Official title: Helmet Noninvasive Ventilation vs. Continuous Positive Airway Pressure vs. High-flow Nasal Oxygen as First-line Treatment of Acute Hypoxemic Respiratory Failure (HENIVOT2). An Open-label, Multicentre Randomized Trial
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05089695 · Data updated 2026-11-12
This study is testing whether helmet ventilation, CPAP, or high-flow oxygen can help people with serious breathing problems avoid needing a breathing tube.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | March 1, 2022 |
| Main results expected | December 2025 |
| Study ends | June 2026 |
| Registry record updated | September 30, 2025 |
| Trial ID | NCT05089695 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with acute respiratory failure characterized by a PaO2/FiO2 ratio of 200 or less, without a history of chronic respiratory failure or significant cardiac issues.
✕Probably not a fit
Patients with chronic respiratory failure, severe cardiac insufficiency, or those who have already received continuous noninvasive ventilation for over 24 hours prior to screening may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, open-label, three-arm randomized trial aims to evaluate the effectiveness of helmet noninvasive ventilation, helmet continuous positive airway pressure (CPAP), and high-flow nasal oxygen in reducing the need for endotracheal intubation in patients suffering from acute moderate-to-severe hypoxemic respiratory failure. The study will assess the intubation rates and days free from respiratory support over a 28-day period. By comparing these three noninvasive respiratory support methods, the trial seeks to identify the most effective initial management strategy for this critical condition.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with hypoxemic respiratory failure, potentially reducing the need for invasive intubation.
How similar studies have gone: Previous studies have shown promising results for helmet noninvasive ventilation compared to other methods, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute symptoms of respiratory failure PaO2/FiO2 ratio ≤ 200; PaCO2≤45mmHg; Absence of history of chronic respiratory failure or moderate to severe cardiac insufficiency (NYHA\>2 or left ventricular ejection fraction\<50%); Informed consent Patients that have already received NIV, CPAP continuously for more than 24 hours before the screening visit will be excluded. Other Exclusion Criteria: * Pregnancy; * Exacerbation of asthma or chronic obstructive pulmonary disease; * Hypercapnia (PaCO2\>45 mmHg) with or without respiratory acidosis; * More than 2 organ failures, including the lung. * Documented pneumothorax; * Clinical diagnosis of Cardiogenic pulmonary edema; * Haemodynamic instability (Systolic blood pressure\<90 mmHg or mean arterial pressure\<65mmHg) and/or lactic acidosis (lactate\>5 mmol/L) and/or clinically diagnosed Shock requiring administration of vasoactive agents (norepinephrine\>0.1 mcg/Kg/min); * Metabolic Acidosis (pH \<7.30 with normal- or hypo-carbia); * Chronic kidney failure requiring dialysis before ICU admission; * Chronic hypoxemic respiratory failure requiring long-term oxygen therapy; * Altered neurological status that requires immediate intubation and/or making the patient uncooperative; * Urgent need for endotracheal intubation, according to the decision of the attending physician; * Do not intubate order; * Decision of withdrawal of life-sustaining therapy; * Thoracic or abdominal surgery in the previous 7 days; * Any condition that makes the patient very likely to require endotracheal intubation due to a reason different from respiratory failure; * Recent head surgery or anatomy that prevent the application of helmet or HFNC to patient's face.
Where it's running
-
Gemelli
Rome, Italy Recruiting
Study contacts
- Principal investigator: Domenico Luca Grieco, MD — Fondazione Policlinico A. Gemelli IRCCS
- Study coordinator: Domenico Luca Grieco, MD
- Email: dlgrieco@outlook.it
- Phone: +393397681623
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HFNC During Bronchoscopy for Respiratory Failure
This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Epidural spinal cord stimulation to help breathing after cervical spinal cord injury
This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Ciprofol versus propofol for sedating adult ICU patients on noninvasive respiratory support
See if ciprofol works better than propofol for sedating adults in the ICU who are receiving noninvasive ventilation, high-flow nasal cannula, or oxygen therapy.
-
Using EEG to monitor sleep quality in ICU patients with respiratory failure
We will test whether continuous EEG monitoring can better track sleep quality than nurse observations in conscious adults hospitalized in the ICU for acute respiratory failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.